References
Hamblin TJ. Chronic lymphocytic leukaemia. Balliere’s Clin Haematol 1987; 1: 449–91
Cartwright RA, Alexander FE, McKinney PA, et al. Leukaemia and lymphoma. An atlas of distribution within areas of England and Wales 1984–8. London: Leukaemia Research Fund, 1990
Kalil N, Cheson BD. Management of chronic lymphocytic leukaemia. Drugs Aging 2000 Jan; 16(1): 9–27
Hamblin TJ. Achieving optimal outcomes in chronic lymphocytic leukaemia. Drugs 2001; 61(5): 593–611
Binet J-L, Leporier M, Dighiero G, et al. A clinical staging of chronic lymphocytic leukemia. Cancer 1977; 40: 855–64
Rai KR, Sawitsky A, Cronkite ER, et al. Clinical staging of chronic lymphocytic leukemia. Blood 1977; 46: 219–34
Montserrat, Vinolas E, Reverter JC, et al. Natural history of chronic lymphocytic leukemia; on the progression and prognosis of early clinical stages. Nouv Rev Fr Hematol 1988; 30: 359–61
British National Formulary No. 41. London: The Pharmaceutical Press, 2001 Mar
Rai KR, Peterson BL, Appelbaum FR et al. Fludarabine compared with chlorambucil as primary therapy for chronic lymphocytic leukemia. N Engl J Med 2000 Dec; 343(24): 1750–7
Jacksic B, Brugiatelli H. High dose continuous chlorambucil vs intermittent chlorambucil plus prednisolone for treatment of B CLL: IGCI CLL-01 trial. Nouv Rev Fr Hematol 1988; 30: 437–42
Spriano M, Chiurazzi F, Liso V, et al. Multicentre prospective randomized trial of fludarabine versus chlorambucil and prednisone in previously untreated patients with active B-CLL [abstract P086]. IWCLL VIII International Workshop on Chronic Lymphocytic Leukemia; 1999 Oct; Paris
Cheson BD. Therapy for previously untreated chronic lymphocytic leukaemia: a re-evaluation. Semin Hematol 1998; 35: 14–21
Hamblin TJ. Autoimmune disease and its management in CLL. In: Cheson BD, editor. Chronic lymphocytic leukemia: scientific advances and clinical developments. New York: Marcel Dekker, 2nd edition. In press
Tertian G, Cartron J, Bayle C, et al. Fatal intravascular autoimmune hemolytic anaemia after fludarabine treatment for chronic lymphocytic leukemia. Hematol Cell Ther 1996; 38: 359–60
Juliusson G, Christiansen I, Hansen MM, et al. Oral cladribine as primary therapy for patients with B-cell chronic lymphocytic leukemia. J Clin Oncol 1996; 14: 2160–6
Gribben JG, Barlett-Pandite L, Provan A, et al. Disease free status and absence of PCR detectable minimal residual disease suggests eradication of B-CLL following autologous and allogeneic BMT. Blood 1995; 86 Suppl 1: 457
Khouri IF, Keating M, Korbling M, et al. Transplant-lite: induction of graft-v-malignancy using fludarabine-based non-ablative chemotherapy and allogeneic blood progenitor cell transplantation as treatment for lymphoid malignancies. J Clin Oncol 1998; 16: 2817–24
Rights and permissions
About this article
Cite this article
Chlorambucil is still an appropriate first-line therapy for chronic lymphocytic leukaemia. Drugs Ther. Perspect 17, 8–12 (2001). https://doi.org/10.2165/00042310-200117200-00003
Published:
Issue Date:
DOI: https://doi.org/10.2165/00042310-200117200-00003